acrodermatitis chronica atrophicans: An acrodermatitis characterized by a chronically progressive course, leading to widespread atrophy of the skin. It is a clinical manifestation of Lyme borreliosis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
51 |
4. Check minimum number of eventsNone |
51 |
5. Include endpointsNone |
51 |
6. Filter based on genotype QC (FinnGen only) |
51 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L90
- Name in latin
- Acrodermatitis chronica atrophicans
Similar endpoints
↥List of similar endpoints to
Acrodermatitis chronica atrophicans
based on the number of shared cases.
Similar with more cases:
- Atrophic disorders of skin
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 334 | 248 | 84 |
| Only index persons | 309 | 234 | 75 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 62.27 | 64.11 | 57.42 |
| Only index persons | 62.64 | 64.30 | 57.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 51 | 33 | 18 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 64.19 | 64.31 | 63.97 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
11
15
9.07
7.88
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
52
4.80
6.13
1.3
1.3
titre
496.0
805.3
—
5
15
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
12
8.82
4.57
1.1
1.2
g/l
1.2
1.1
—
9
12
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
12
8.82
4.57
1.1
1.2
g/l
0.3
0.2
—
9
12
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
13
7.06
3.66
1.5
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
86
2.93
3.13
1.5
1.2
iu/ml
35.5
40.8
—
5
35
(3015736) pH of Urine
29
171
2.61
2.81
3.6
3.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
25
140
2.54
2.66
7.5
5.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
7
7.75
2.60
1.4
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
16
4.89
2.57
1.1
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
43
324
3.08
2.52
5.4
4.5
mm/h
12.4
11.7
0.11
38
289
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
8
6.78
2.42
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
13
5.07
2.34
1.3
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
174
2.35
2.29
2.6
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
41
305
2.76
2.20
5.0
4.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
16
4.10
2.00
12.8
7.3
mmol/l
26.5
25.0
—
6
16
(3000330) Specific gravity of Urine by Test strip
7
22
3.52
1.96
2.7
3.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
28
192
2.02
1.62
8.1
7.9
e9/l
0.0
0.0
0.50
23
156
(3000494) Fungus identified in Specimen by Culture
11
52
2.42
1.58
1.7
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
13
68
2.22
1.50
2.5
3.2
mmol/l
0.8
0.8
0.47
13
63
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
68
2.22
1.50
1.8
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
9
41
2.45
1.46
1.3
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
109
2.01
1.44
10.8
8.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
17
3.14
1.39
2.0
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
10
48
2.35
1.38
2.3
2.4
umol/l
5.3
7.7
—
10
43
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
78
2.10
1.38
1.5
1.2
u/ml
1.4
14.2
—
5
31
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
24
2.69
1.34
2.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
36
2.44
1.31
18.6
8.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
35
0.00
1.20
0.0
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
20
2.66
1.18
8.2
6.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
10
53
2.10
1.10
1.9
3.6
%
1.8
1.6
—
10
48
(40760892) CBC W Ordered Manual Differential panel - Blood
15
93
1.87
1.09
3.3
4.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
21
145
1.76
1.09
2.6
2.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
9
51
1.93
1.01
8.2
4.0
mmol/l
1.1
1.1
—
9
46
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
31
0.00
1.00
0.0
7.5
—
24.4
—
0
31
(3009542) Hematocrit [Volume Fraction] of Blood
44
388
1.97
0.93
25.0
15.3
%
39.0
39.8
0.23
33
262
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
32
1.99
0.85
1.7
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
22
164
1.60
0.82
6.0
8.5
inr
1.2
1.3
—
6
48
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
25
0.00
0.81
0.0
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
102
1.67
0.79
4.5
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
26
2.02
0.73
1.4
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
22
168
1.54
0.72
3.8
3.4
e6/l
12.8
52.0
1.75
15
119
(36660697) Celiac disease serology panel - Serum
7
42
1.77
0.72
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
18
132
1.56
0.70
4.0
2.2
u/l
75.8
58.1
0.53
18
121
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
179
1.52
0.69
2.2
2.0
pmol/l
111.0
92.3
—
10
83
(3014007) Fractional oxyhemoglobin in Arterial blood
5
28
1.87
0.68
8.8
9.0
%
94.0
93.8
—
5
28
(36304419) Bacteria [Presence] in Urine
18
134
1.53
0.65
3.2
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
51
1.67
0.64
1.9
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
29
240
1.48
0.63
8.7
6.3
umol/l
12.2
11.0
0.39
29
225
(3018405) Lactate [Moles/volume] in Arterial blood
0
21
0.00
0.61
0.0
3.9
—
1.4
—
0
21
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
92
1.55
0.58
2.5
2.4
e6/l
0.6
1.1
—
7
54
(3019832) Treponema pallidum Ab [Presence] in Serum
6
38
1.65
0.56
1.3
2.0
—
—
—
0
0
(4035726)
6
39
1.61
0.55
1.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
13
93
1.53
0.55
1.1
1.4
g/l
6.3
2.6
—
7
45
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
68
1.59
0.51
3.7
7.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
46
1.60
0.51
1.9
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
21
170
1.40
0.48
3.9
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
45
417
1.67
0.48
19.0
13.1
ml/min/173m2
77.8
79.7
0.27
37
337
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
31
1.68
0.44
8.8
8.2
%
0.4
0.7
—
5
31
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
31
1.68
0.44
8.8
8.3
%
1.3
1.5
—
5
31
(3002179) Metamyelocytes/100 leukocytes in Blood
5
32
1.62
0.43
1.4
4.1
—
0.3
—
0
6
(3042936) Bacteria identified in Isolate by Culture
8
60
1.39
0.43
1.9
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
15
117
1.40
0.41
3.3
3.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
5
35
1.47
0.40
1.4
4.2
—
0.0
—
0
8
(3025159) Blasts/100 leukocytes in Blood
5
35
1.47
0.40
1.4
4.1
—
0.0
—
0
7
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
35
1.47
0.40
2.8
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
143
0.71
0.39
4.0
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
82
1.44
0.38
2.6
2.8
e6/l
6.8
4.0
—
5
45
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
42
1.48
0.37
9.3
7.5
g/l
112.0
121.3
—
6
42
(3007853) Bacteria identified in Skin by Aerobe culture
6
42
1.48
0.37
4.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
20
167
1.33
0.36
4.3
3.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
45
1.38
0.35
1.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
168
1.31
0.34
2.5
4.1
ng/l
27.7
25.8
0.04
11
120
(3022217) INR in Platelet poor plasma by Coagulation assay
7
55
1.32
0.31
34.0
27.7
—
1.5
—
0
6
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
65
1.27
0.29
2.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
5
38
1.35
0.24
1.4
4.0
—
0.6
—
0
9
(40761535) Cells panel - Urine sediment
5
40
1.28
0.23
5.6
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
112
0.76
0.23
4.6
5.3
ug/l
2.1
2.3
—
9
96
(3012544) pH of Venous blood
5
41
1.24
0.22
20.8
3.6
—
—
—
0
0
(4010399)
5
42
1.21
0.22
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.7
—
86.1
—
0
10
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
10
0.00
0.21
0.0
6.3
—
1.0
—
0
10
(3027944) Amphetamines [Presence] in Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
204.7
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
6
48
1.28
0.21
9.2
7.0
mmol/l
0.5
1.7
—
6
38
(3027801) Oxygen [Partial pressure] in Arterial blood
6
48
1.28
0.21
9.3
7.0
kpa
11.9
11.4
—
6
48
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6
48
1.28
0.21
9.5
7.0
kpa
5.3
5.0
—
6
48
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.8
—
73.5
—
0
8
(4034850)
0
13
0.00
0.21
0.0
7.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
14
0.00
0.20
0.0
1.7
—
132.4
—
0
8
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
60
1.19
0.19
1.6
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
101
1.25
0.18
2.3
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
37
350
1.21
0.17
13.2
7.6
u/l
77.2
80.4
0.18
37
319
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
43
1.18
0.10
2.8
2.4
—
—
—
0
0
(3019225) pH of Specimen
5
46
1.10
0.10
3.6
4.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
73
0.80
0.08
1.7
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
74
0.79
0.08
1.8
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
44
431
1.15
0.08
4.7
4.6
mmol/l
4.8
4.6
0.52
38
400
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
43
418
1.18
0.07
6.0
6.3
mmol/mol
38.1
40.0
1.10
37
390
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
43
418
1.18
0.07
4.3
4.1
mmol/l
1.1
1.3
0.91
37
380
(3003694) ABO and Rh group [Type] in Blood
11
120
0.89
0.05
1.5
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
14
130
1.11
0.05
2.6
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
206
0.95
0.00
3.9
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
111
0.99
0.00
3.8
3.9
—
—
—
0
0
(3013512) EKG study
14
139
1.01
0.00
3.6
4.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
241
0.99
0.00
3.2
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
30
303
0.98
0.00
3.8
3.9
—
—
—
0
0
(3039000) Anion gap in Blood
0
7
0.00
0.00
0.0
6.0
—
10.3
—
0
7
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
16.5
—
0
9
(3022948) Iron [Moles/volume] in Serum or Plasma
7
71
0.98
0.00
3.7
2.1
umol/l
15.2
14.1
—
7
63
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6
65
0.91
0.00
4.2
2.1
g/l
2.5
2.4
—
6
58
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
4.2
—
176.9
—
0
9
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
7
0.00
0.00
0.0
6.0
—
103.0
—
0
7
(3028707) Methadone [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
3.6
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
6
0.00
0.00
0.0
1.8
—
162.0
—
0
6
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
3.1
—
3.9
—
0
7
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
12.2
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
5.4
—
0
5
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
3.1
—
108.4
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
43
429
1.01
0.00
4.8
4.7
mmol/l
1.6
1.5
0.49
37
393
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
63
0.95
0.00
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
44
440
1.00
0.00
5.1
5.3
mmol/l
2.9
2.7
0.66
38
407
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_ACRODERMATITIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_ACRODERMATITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_ACRODERMATITIS – Acrodermatitis chronica atrophicans
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data